Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
772 studies found for:    Open Studies | "Blood Coagulation Disorders"
Show Display Options
Rank Status Study
21 Recruiting Motor Proficiency of People With Bleeding Disorders Using the BOT-2 (TM)
Condition: Hemophilia
Intervention:
22 Recruiting Implementing Treatment Algorithms for the Correction of Trauma Induced Coagulopathy
Conditions: Hemorrhage;   Coagulopathy;   Trauma
Intervention: Device: VHA algorithm
23 Recruiting Ex Vivo Laboratory Assays Application for Therapy Tailoring in Patients With Severe Bleeding Disorders
Condition: Severe Hemophilia
Intervention:
24 Recruiting Bedside Evaluation of Coagulation in Children With Congenital Heart Disease
Conditions: Congenital Heart Defect;   Blood Coagulation Disorder
Intervention:
25 Recruiting Coagulopathy and SIRS During ECC in Intensive Care
Condition: Disorder of Circulatory System
Intervention: Device: ECLS/ECC
26 Recruiting Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency
Condition: Benign Prostatic Hyperplasia
Interventions: Procedure: HoLEP;   Procedure: Greenlight laser PVP
27 Recruiting Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia
Condition: Acute Promyelocytic Leukemia
Intervention:
28 Recruiting Swiss Hemophilia Registry
Condition: Hemophilia and Other Severe Bleeding Disorders
Intervention: Other: Registry
29 Not yet recruiting Thromboelastometry in Liver Transplantation
Conditions: Liver Transplant Disorder;   Coagulopathy
Intervention: Other: Fibrinogen and/or platelets administration
30 Recruiting Post-Marketing Requirement to Evaluate the Safety of Octaplas™ Versus Plasma in Patients Undergoing Orthotopic Liver Transplantation With Special Emphasis on Hyperfibrinolysis.
Conditions: Coagulopathy;   Endstage Liver Disease
Interventions: Biological: Octaplas™;   Biological: Plasma
31 Not yet recruiting Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder
Condition: Inherited Platelet Disorders
Intervention: Other: Blood collection for platelet protein samples
32 Recruiting Fibrinogen as a Surrogate for Global Haemostasis in Plasma Exchange
Conditions: Clotting Disorder Due to Plasma Exchange Therapy;   Humoral Rejection After Kidney Transplantation
Intervention:
33 Not yet recruiting PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding
Conditions: Bleeding;   Blood Loss, Surgical;   Cardiovascular Surgical Procedures;   Prothrombin Complex Concentrates;   Fresh Frozen Plasma
Interventions: Drug: Prothrombin complex concentrate (Human);   Biological: Fresh frozen plasma (FFP)
34 Recruiting Treatment of Coagulopathy Trauma-induced Guided by Thromboelastography in Politrauma Patients.
Condition: Trauma; Hemorrhage, Complicating Delivery
Intervention: Drug: Fibrinogen concentrate
35 Recruiting Pre-hospital Administration of Lyophilized Plasma for Post-traumatic Coagulopathy Treatment (PREHO-PLYO)
Condition: Shock Hemorrhagic
Interventions: Biological: French Lyophilized Plasma;   Biological: Normale Saline Solution
36 Not yet recruiting Safety, Tolerability, and Pharmacokinetics Study of Turoctocog Alfa Pegol Injected Under the Skin in Patients With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa pegol
37 Recruiting Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
38 Recruiting A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa pegol
39 Recruiting To Investigate Safety and Efficacy of NovoEight® (rFVIII) During Long-term Treatment of Haemophilia A in Japan
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa
40 Recruiting Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A
Conditions: Congenital Bleeding Disorder;   Haemophilia A
Intervention: Drug: turoctocog alfa pegol

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.